Clinicopathological Analysis of B Cell Lymphomas, Unclassifiable; with Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma in a Tertiary Care Hospital in Southern India

Kluin PM, Harris NL, Stein H, Leoncini L, Raphael M, Campo E et al (2008) B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. In: Swerdlow SH, Campo E et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC Press, Lyon, pp 265–266

Rudiger T, Jaffe ES, Delsol G, deWolf-Peeters C, Gascoyne RD, Georgii A et al (1998) Workshop report on Hodgkin’s disease and related diseases (‘grey zone’ lymphoma). Ann Oncol 9:S31–S38

Aukema SM, Siebert R, Schuuring E, van Imhoff GW, Kluin-Nelemans HC, Boerma EJ et al (2011) Double-hit B-cell lymphomas. Blood 117:2319–2331

Carbone A, Gloghini A, Aiello A, Testi A, Cabras A (2010) B-cell lymphomas with features intermediate between distinct pathologic entities. From pathogenesis to pathology. Hum Pathol 41:621–631

Quintanilla-Martinez L, de Jong D, de Mascarel A, Hsi ED, Kluin P, Natkunam Y et al (2009) Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, France. J Hematop 2:211–236

Le Gouill S, Talmant P, Touzeau C, Moreau A, Garand R, Juge-Morineau N et al (2007) The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement. Haematologica 92:1335–1342

Bellan C, Stefano L, de Giulia F, Rogena EA, Lorenzo L (2009) Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach. Hematol Oncol 27:182–185

Hasserjian RP, Ott G, Elenitoba-Johnson KS, Balague-Ponz O, de Jong D, de Leval L (2009) Commentary on the WHO classification of tumors of lymphoid tissues (2008): “Gray zone” lymphomas overlapping with Burkitt lymphoma or classical Hodgkin lymphoma. J Hematop 2:89–95

Cigudosa JC, Parsa NZ, Louie DC, Filippa DA, Jhanwar SC, Johansson B et al (1999) Cytogenetic analysis of 363 consecutively ascertained diffuse large B-cell lymphomas. Genes Chromosom Cancer 25:123–133

Savage KJ, Johnson NA, Ben-Neriah S, Connors JM, Sehn LH, Farinha P et al (2009) MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy. Blood 114:3533–3537

Barrans S, Crouch S, Smith A, Turner K, Owen R, Patmore R et al (2010) Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab. J Clin Oncol 28:3360–3365

Salaverria I, Siebert R (2011) The gray zone between Burkitt’s lymphoma and diffuse large B-cell lymphoma from a genetics perspective. J ClinOncol 29:1835–1843

Johnson NA, Savage KJ, Ludkovski O, Ben-Neriah S, Woods R, Steidl C et al (2009) Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival. Blood 114:2273–2279

Poirel HA, Cairo MS, Heerema NA, Swansbury J, Aupérin A, Launay E et al (2009) Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin’s lymphoma: Results of the FAB/LMB 96 international study. Leukemia 23:323–331

Boerma EG, Siebert R, Kluin PM, Baudis M (2009) Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: A historical review of cytogenetics in the light of todays knowledge. Leukemia 23:225–234

Klapper W, Szczepanowski M, Burkhardt B, Berger H, Rosolowski M, Bentink S et al (2008) Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials. Blood 112:1374–1381

Perry AM, Crockett D, Dave BJ, Althof P, Winkler L, Smith LM et al (2013) B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and burkitt lymphoma: study of 39 cases. Br J Haematol 162(1):40–49

Bürgesser MV, Gualco G, Diller A, Natkunam Y, Bacchi CE (2013) Clinicopathological features of aggressive B-cell lymphomas including B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell and Burkitt lymphomas: a study of 44 patients from Argentina. Ann Diagn Pathol 17(3):250–255

Edwards L, Krakow F, Bhagirath VC, Christine Keng C, Lytwyn A (2014) B-cell Lymphoma Unclassifiable with Features Intermediate between Diffuse Large B-cell Lymphoma and Burkitt’s Lymphoma: Comparison study of clinical outcome and treatment response. J Clin Anat Pathol 2:1–8

Jaradat JM, Potluri A, Bilodeau EA (2013) B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma: Report of a case in the oral cavity. Indian J Dent Res 24:384–386

Ahn JY, Seo YH, Park PW, Kim KH, Park MJ, Jeong JH et al (2012) A case of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma in a Korean child. Ann Lab Med 32:162–166

Zhang S, Wilson D, Czader M (2015) Pediatric B-cell lymphoma, unclassifiable, with intermediate features between those of diffuse large B-cell lymphoma and Burkitt lymphoma: a report of two cases. Ann Lab Med 35(2):254